Showing codes J9304 (Injection, pemetrexed (pemfexy), 10 mg) — J9347 (Injection, tremelimumab-actl, 1 mg)

J9304 - Inj. pemetrexed, 10 mg
Long description: Injection, pemetrexed (pemfexy), 10 mg
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9305 - Inj. pemetrexed nos 10mg
Long description: Injection, pemetrexed, not otherwise specified, 10 mg
Code added date: 20050101.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9306 - Injection, pertuzumab, 1 mg
Long description: Injection, pertuzumab, 1 mg
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9307 - Pralatrexate injection
Long description: Injection, pralatrexate, 1 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9308 - Injection, ramucirumab
Long description: Injection, ramucirumab, 5 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9309 - Inj, polatuzumab vedotin 1mg
Long description: Injection, polatuzumab vedotin-piiq, 1 mg
Code added date: 20200101.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9310 - Rituximab injection
Long description: Injection, rituximab, 100 mg
Code added date: 19990101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9311 - Inj rituximab, hyaluronidase
Long description: Injection, rituximab 10 mg and hyaluronidase
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9312 - Inj., rituximab, 10 mg
Long description: Injection, rituximab, 10 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9313 - Inj., lumoxiti, 0.01 mg
Long description: Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9314 - Inj pemetrexed (teva) 10mg
Long description: Injection, pemetrexed (teva) not therapeutically equivalent to j9305, 10 mg
Code added date: 20230101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9315 - Romidepsin injection
Long description: Injection, romidepsin, 1 mg
Code added date: 20110101.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9316 - Pertuzu, trastuzu, 10 mg
Long description: Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9317 - Sacituzumab govitecan-hziy
Long description: Injection, sacituzumab govitecan-hziy, 2.5 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9318 - Inj romidepsin non-lyo 0.1mg
Long description: Injection, romidepsin, non-lyophilized, 0.1 mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9319 - Inj romidepsin lyophil 0.1mg
Long description: Injection, romidepsin, lyophilized, 0.1 mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9320 - Streptozocin injection
Long description: Injection, streptozocin, 1 gram
Code added date: 19860101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9321 - Inj epcoritamab-bysp 0.16 mg
Long description: Injection, epcoritamab-bysp, 0.16 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9322 - Inj pemetrexed (bluepoint)
Long description: Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9323 - Inj pemetrexed ditromethamin
Long description: Injection, pemetrexed ditromethamine, 10 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9324 - Inj, pemrydi rtu, 10 mg
Long description: Injection, pemetrexed (pemrydi rtu), 10 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9325 - Inj talimogene laherparepvec
Long description: Injection, talimogene laherparepvec, per 1 million plaque forming units
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9328 - Temozolomide injection
Long description: Injection, temozolomide, 1 mg
Code added date: 20100101.
Code effective date: 20100101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9330 - Temsirolimus injection
Long description: Injection, temsirolimus, 1 mg
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9331 - Inj sirolimus prot part 1 mg
Long description: Injection, sirolimus protein-bound particles, 1 mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9332 - Inj efgartigimod 2mg
Long description: Injection, efgartigimod alfa-fcab, 2mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9333 - Inj ronzanolixizum-noli 1 mg
Long description: Injection, rozanolixizumab-noli, 1 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9334 - Inj efgart-alfa 2mg hya-qvfc
Long description: Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9340 - Thiotepa injection
Long description: Injection, thiotepa, 15 mg
Code added date: 19840101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9345 - Inj, retifanlimab-dlwr, 1 mg
Long description: Injection, retifanlimab-dlwr, 1 mg
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9347 - Inj, tremelimumab-actl, 1 mg
Long description: Injection, tremelimumab-actl, 1 mg
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF